Local and systemic application of tranexamic acid in heart valve surgery: A prospective, randomized, double blind LOST study

Journal of Thrombosis and Thrombolysis

Volumn 32, Issue 3, 2011, Pages 303-310

  Spegar, Jan ^a   Vanek, Tomas ^a   Snircova, Jana ^a   Fajt, Richard ^a   Straka, Zbynek ^a   Pazderkova, Petra ^a   Maly, Marek ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

Fibrinolysis; Fibrinolytic inhibitors; Heart valve surgery; Tranexamic acid

Indexed keywords

FRESH FROZEN PLASMA; PLACEBO; TRANEXAMIC ACID;

AGED; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEART VALVE SURGERY; HUMAN; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PLASMA TRANSFUSION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL APPROACH; SUTURING METHOD; SYSTEMIC THERAPY; TREATMENT INDICATION;

AGED; ANTIFIBRINOLYTIC AGENTS; BLOOD COMPONENT TRANSFUSION; CARDIAC SURGICAL PROCEDURES; DOUBLE-BLIND METHOD; FEMALE; HEART VALVES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; TIME FACTORS; TRANEXAMIC ACID;

EID: 82955213053     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0608-3     Document Type: Article

References (29)

1. Royston D, Taylor KM, Bidstrup BP, Sapsford RN (1987) Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 330:1289-1291 (Pubitemid 17156632)
2. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B, Laupacis A, Fergusson D (2007) Anti-fibrinolytic use for minimising perioperative allogenic blood transfusion. Cochrane Database Syst Rev:CD001886
3. Karkouti K, Beattie WS, Dattilo KM, McCluskey SA, Ghannam M, Hamdy A, Wijeysundera DN, Fedorko L, Yau TM (2006) A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 46:327-338 (Pubitemid 43334084)
4. Mangano DT, Tudor IC, Dietzel C (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354:353-365 (Pubitemid 43145060)
5. Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussières JS, Ĉté D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R (2008) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358:2319-2331 (Pubitemid 351749156)
6. Ngaage DL, Bland JM (2010) Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomized and large matched observational studies. Eur J Cardiothorac Surg 37:1375-1383
7. De Bonis M, Cavaliere F, Alessandrini F, Lapenna E, Santarelli F, Moscato U, Schiavello R, Poostli GF (2000) Topical use of tranexamic acid in coronary artery bypass operations: a doubleblind, prospective, randomized, placebo-controlled study. J Thorac Cardiovasc Surg 119:575-580 (Pubitemid 30146538)
8. Abul-Azm A, Abdullah KM (2006) Effect of topical tranexamic acid in open heart surgery. Eur J Anaesthesiol 23:380-384
9. Baric D, Biocina B, Unic D, Sutlic Z, Rudez I, Vrca VB, Brkic K, Ivkovic M (2007) Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study. Eur J Cardiothorac Surg 31:366-371 (Pubitemid 46329403)
10. Fawzy H, Elmistekawy E, Bonneau D, Latter D, Errett L (2009) Can local application of tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial. J Cardiothorac Surg 4:25. doi:10.1186/1749-8090-4- 25
11. Abrishami A, Chung F, Wong J (2009) Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis. Can J Anaesth 56:202-212
12. Sankoh AJ, Huque MF, Dubey SD (1997) Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 16:2529-2542 (Pubitemid 27490059)
13. Despotis GJ, Avidan MS, Hogue CW Jr (2001) Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 72:S1821-S1831 (Pubitemid 33049834)
14. Biglioli P, Cannata A, Alamanni F, Naliato M, Porqueddu M, Zanobini M, Tremoli E, Parolari A (2003) Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress. Eur J Cardiothorac Surg 24:260-269 (Pubitemid 36952192)
15. Edmunds LH Jr, Colman RW (2006) Thrombin during cardiopulmonary bypass. Ann Thorac Surg 82:2315-2322 (Pubitemid 44794379)
16. Lobato RL, Despotis GJ, Levy JH, Shore-Lesserson LJ, Carlson MO, Bennett-Guerro E (2010) Anticoagulation management during cardiopulmonary bypass: a survey of 54 North American institutions. J Thorac Cardiovasc Surg 139:1665-1666
17. Shann KG, Likosky DS, Murkin JM, Baker RA, Baribeau YR, DeFoe GR, Dickinson TA, Gardner TJ, Grocott HP, O'Connor GT, Rosinski DJ, Sellke FW, Willcox TW (2006) An evidencebased review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg 132: 283-290
18. Ranucci M, Castelvecchio S, Romitti F, Isgrò G, Ballotta A, Conti D (2009) Living without aprotinin: the results of a 5-year blood saving program in cardiac surgery. Acta Anaesthesiol Scand 53:573-580
19. Later AF, Maas JJ, Engbers FH, Versteegh MI, Bruggemans EF, Dion RA, Klautz RJ (2009) Tranexamic acid and aprotinin in low-and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. Eur J Cardiothorac Surg 36:322-329
20. Tabuchi N, de Haan J, Boonstra PW, van Oeveren W (1993) Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Cardiovasc Surg 106:828-833 (Pubitemid 23335811)
21. Khalil PN, Ismail M, Kalmar P, von Knobelsdorff G, Marx G (2004) Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass. Thromb Haemost 92:568-574 (Pubitemid 39248013)
22. Jimenez JJ, Iribarren JL, Lorente L, Rodriguez JM, Hernandez D, Nassar I, Perez R, Brouard M, Milena A, Martinez R, Mora ML (2007) Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care 11:R117. doi:10.1186/cc6173 (Pubitemid 351150059)
23. Robertshaw HJ (2008) An anti-inflammatory role for tranexamic acid in cardiac surgery? Crit Care 12:105. doi:10.1186/cc6210
24. Jares M, Vanek T, Bednar F, Maly M, Snircova J, Straka Z (2007) Off-pump versus on-pump coronary artery surgery-identification of fibrionolysis using rotation thromboelastography; A preliminary, prospective, randomized study. Int Heart J 48:57-67 (Pubitemid 46522733)
25. Vanek T, Jares M, Snircova J, Maly M (2007) Fibrinolysis in coronary artery surgery: detection by thromboelastography. Interact Cardiovasc Thorac Surg 6:700-704 (Pubitemid 350291679)
26. Ranucii M, Bozzeti G, Ditta A, Cotza M, Carboni G, Ballotta A (2008) Surgical reexploration after cardiac operations: why a worse outcome? Ann Thorac Surg 86:1557-1562
27. Mataraci I, Polat A, Toker ME, Tezcan O, Erkin A, Kirali K (2010) Postoperative revision surgery for bleeding in a tertiary heart center. Asian Cardiovasc Thorac Ann 18:266-271
28. Karthik S, Grayson AD, McCarron EE, Pullam DM, Desmond MJ (2004) Reexploration for bleeding after coronary bypass surgery: risk factors, outcomes, and effects of time delay. Ann Thorac Surg 78:527-534 (Pubitemid 38980767)
29. Choong CK, Gerrard C, Goldsmith KA, Dunningham H, Vuylsteke A (2007) Delayed re-exploration for bleeding after coronary artery bypass surgery results in adverse outcomes. Eur J Cardiothorac Surg 31:834-838